PMID- 16195383 OWN - NLM STAT- MEDLINE DCOM- 20060420 LR - 20181201 IS - 0027-8424 (Print) IS - 1091-6490 (Electronic) IS - 0027-8424 (Linking) VI - 102 IP - 41 DP - 2005 Oct 11 TI - Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. PG - 14659-64 AB - Menin, the product of the Men1 gene mutated in familial multiple endocrine neoplasia type 1 (MEN1), regulates transcription in differentiated cells. Menin associates with and modulates the histone methyltransferase activity of a nuclear protein complex to activate gene expression. However, menin-dependent histone methyltransferase activity in endocrine cells has not been demonstrated, and the mechanism of endocrine tumor suppression by menin remains unclear. Here, we show that menin-dependent histone methylation maintains the in vivo expression of cyclin-dependent kinase (CDK) inhibitors to prevent pancreatic islet tumors. In vivo expression of CDK inhibitors, including p27 and p18, and other cell cycle regulators is disrupted in mouse islet tumors lacking menin. Chromatin immunoprecipitation studies reveal that menin directly associates with regions of the p27 and p18 promoters and increases methylation of lysine 4 (Lys-4) in histone H3 associated with these promoters. Moreover, H3 Lys-4 methylation associated with p27 and p18 is reduced in islet tumors from Men1 mutant mice. Thus, H3 Lys-4 methylation is a crucial function of menin in islet tumor suppression. These studies suggest an epigenetic mechanism of tumor suppression: by promoting histone modifications, menin maintains transcription at multiple loci encoding cell cycle regulators essential for endocrine growth control. FAU - Karnik, Satyajit K AU - Karnik SK AD - Departments of Developmental Biology and Medicine (Oncology Division), Stanford University School of Medicine, Stanford, CA 94305-5329. FAU - Hughes, Christina M AU - Hughes CM FAU - Gu, Xueying AU - Gu X FAU - Rozenblatt-Rosen, Orit AU - Rozenblatt-Rosen O FAU - McLean, Graeme W AU - McLean GW FAU - Xiong, Yue AU - Xiong Y FAU - Meyerson, Matthew AU - Meyerson M FAU - Kim, Seung K AU - Kim SK LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. DEP - 20050929 PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Cyclin-Dependent Kinase Inhibitor p18) RN - 0 (Histones) RN - 0 (Men1 protein, mouse) RN - 0 (Proto-Oncogene Proteins) RN - 147604-94-2 (Cyclin-Dependent Kinase Inhibitor p27) RN - EC 1.13.12.- (Luciferases) RN - EC 2.1.1.- (Histone Methyltransferases) RN - EC 2.1.1.- (Protein Methyltransferases) RN - EC 2.1.1.43 (Histone-Lysine N-Methyltransferase) SB - IM MH - Animals MH - Blotting, Western MH - Chromatin Immunoprecipitation MH - Cyclin-Dependent Kinase Inhibitor p18/*biosynthesis MH - Cyclin-Dependent Kinase Inhibitor p27/*biosynthesis MH - *Gene Expression Regulation MH - Genes, Tumor Suppressor/*physiology MH - Histone Methyltransferases MH - Histone-Lysine N-Methyltransferase/*metabolism MH - Histones/metabolism MH - Islets of Langerhans/*growth & development/metabolism MH - Luciferases MH - Mice MH - Mice, Inbred C57BL MH - Multiple Endocrine Neoplasia Type 1/metabolism MH - Protein Methyltransferases MH - Proto-Oncogene Proteins/*physiology MH - Reverse Transcriptase Polymerase Chain Reaction MH - Tumor Cells, Cultured PMC - PMC1253549 EDAT- 2005/10/01 09:00 MHDA- 2006/04/21 09:00 PMCR- 2006/04/11 CRDT- 2005/10/01 09:00 PHST- 2005/10/01 09:00 [pubmed] PHST- 2006/04/21 09:00 [medline] PHST- 2005/10/01 09:00 [entrez] PHST- 2006/04/11 00:00 [pmc-release] AID - 0503484102 [pii] AID - 010214659 [pii] AID - 10.1073/pnas.0503484102 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14659-64. doi: 10.1073/pnas.0503484102. Epub 2005 Sep 29.